It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Malignant melanoma displays a high degree of cellular plasticity during disease progression. Signals in the tumor microenvironment are believed to influence melanoma plasticity through changes in the epigenetic state to guide dynamic differentiation and de-differentiation. Here we uncover a relationship between geometric features at perimeter regions of melanoma aggregates, and reprogramming to a stem cell-like state through histone marks H3K4Me2 and H3K9Ac. Using an in vitro tumor microengineering approach, we find spatial enrichment of these histone modifications with concurrent expression of stemness markers. The epigenetic modifier PRDM14 overlaps with H3K9Ac and shows elevated expression in cells along regions of perimeter curvature. siRNA knockdown of PRDM14 abolishes the MIC phenotype suggesting a role in regulating melanoma heterogeneity. Our results suggest mechanotransduction at the periphery of melanoma aggregates may orchestrate the activity of epigenetic modifiers to regulate histone state, cellular plasticity, and tumorigenicity.
Junmin Lee et al. study the role of geometric features at the perimeter regions of melanoma aggregates in programming stem cell-like state through histone marks. They use a tumor microengineering approach in vitro and report a spatial enrichment of histone modifications with stemness markers. Their work uncovers a mechanotransduction signaling that regulates epigenetic modifiers to regulate tumorigenicity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Illinois at Urbana-Champaign, Department of Materials Science and Engineering, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991); University of Illinois at Urbana-Champaign, Institute for Genomic Biology, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)
2 University of Illinois at Urbana-Champaign, Department of Materials Science and Engineering, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991); University of New South Wales, School of Chemistry, School of Materials Science and Engineering, Australian Centre for NanoMedicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
3 University of Illinois at Urbana-Champaign, Institute for Genomic Biology, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991); University of Illinois at Urbana-Champaign, Department of Cell and Developmental Biology, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)
4 University of New South Wales, Prince of Wales Clinical School, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
5 University of New South Wales, European Molecular Biology Laboratory Australia Node in Single Molecule Science and ARC Centre of Excellence in Advanced Molecular Imaging, School of Medical Sciences, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
6 University of Illinois at Urbana-Champaign, Department of Materials Science and Engineering, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991); University of Illinois at Urbana-Champaign, Institute for Genomic Biology, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991); University of New South Wales, School of Chemistry, School of Materials Science and Engineering, Australian Centre for NanoMedicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); University of Illinois at Urbana-Champaign, Department of Bioengineering, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)